Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-9-21
pubmed:abstractText
To determine the efficacy of acarbose, compared with placebo, on the metabolic control of NIDDM patients inadequately controlled on maximal doses of conventional oral agents.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acarbose, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Metformin, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Transaminases, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/Trisaccharides
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1154-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9653611-Acarbose, pubmed-meshheading:9653611-Administration, Oral, pubmed-meshheading:9653611-Blood Glucose, pubmed-meshheading:9653611-China, pubmed-meshheading:9653611-Cholesterol, pubmed-meshheading:9653611-Cholesterol, HDL, pubmed-meshheading:9653611-Diabetes Mellitus, Type 2, pubmed-meshheading:9653611-Double-Blind Method, pubmed-meshheading:9653611-Drug Resistance, pubmed-meshheading:9653611-Fasting, pubmed-meshheading:9653611-Female, pubmed-meshheading:9653611-Flatulence, pubmed-meshheading:9653611-Gastrointestinal Diseases, pubmed-meshheading:9653611-Hemoglobin A, Glycosylated, pubmed-meshheading:9653611-Hong Kong, pubmed-meshheading:9653611-Humans, pubmed-meshheading:9653611-Hypoglycemic Agents, pubmed-meshheading:9653611-Insulin, pubmed-meshheading:9653611-Male, pubmed-meshheading:9653611-Metformin, pubmed-meshheading:9653611-Middle Aged, pubmed-meshheading:9653611-Patient Compliance, pubmed-meshheading:9653611-Placebos, pubmed-meshheading:9653611-Postprandial Period, pubmed-meshheading:9653611-Sulfonylurea Compounds, pubmed-meshheading:9653611-Transaminases, pubmed-meshheading:9653611-Treatment Outcome, pubmed-meshheading:9653611-Triglycerides, pubmed-meshheading:9653611-Trisaccharides
pubmed:year
1998
pubmed:articleTitle
Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.
pubmed:affiliation
Department of Medicine, Queen Mary Hospital, Hong Kong, China.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study